Granules India Limited
₹632.4+0.07%Apr 13, 3:45 PM IST
GRANULES•Health Technology•Pharmaceuticals: Other
Current Price
₹632.4+0.07%
Apr 13, 3:45 PM ISTMarket Cap₹15,658.29 Cr
Market Cap₹15,658.29 Cr
Business Overview
Granules India Limited operates through 3 main business divisions including Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI), Finished Dosages (FD).
Business Hierarchy Structure for Granules India Limited
- Granules India Limited
- Active Pharmaceutical Ingredients (API)
- Manufacturing Locations
- Bonthapally, Telangana
- Jeedimetla, Telangana
- Vizag (Unit IV), Andhra Pradesh
- Vizag (Unit V), Andhra Pradesh
- Bonthapally II (API Intermediate)
- Product Categories
- High-Volume First-Line Treatments
- Paracetamol
- Metformin
- Guaifenesin
- Methocarbamol
- Emerging Portfolio
- Oncology APIs
- Large-Volume Molecules APIs
- Anti-diabetic APIs
- High-Volume First-Line Treatments
- Manufacturing Locations
- Pharmaceutical Formulation Intermediates (PFI)
- Manufacturing Locations
- Gagillapur, Telangana
- Jeedimetla, Telangana
- Technology Platforms
- MUPS (Multiple Unit Pellet System) Technologies
- Advanced Delivery Systems (Modified and Delayed-Release Formulations)
- Manufacturing Locations
- Finished Dosages (FD)
- Manufacturing Locations
- Gagillapur
- Virginia, USA
- Vizag (Unit V)
- Granules Life Sciences (GLS)
- Product Forms
- Tablets
- Caplets
- Press-fit Capsules (Bulk)
- Press-fit Capsules (Blister Packs)
- Press-fit Capsules (Bottles)
- Oral Solutions
- Suspensions
- Powders for Oral Solutions
- Therapeutic Segments / Product Pipelines
- Oncology Formulations
- CNS/ADHD Formulations (Controlled Substances)
- Anti-diabetic Formulations
- Large Volume Molecules Formulations
- Innovation based Products (Enzyme/Continuous Manufacturing)
- New Dosage Forms (Expanding beyond Oral Solid Dosages)
- Manufacturing Locations
- Active Pharmaceutical Ingredients (API)